ERICA GERSTENMAIER: Open Payments
NPI 1588822639 · FAIRLAWN, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$497 in 25 payments from 7 companies in 2025. Trend: 2023 $1,007 · 2024 $693 · 2025 $497
Food & beverage: $497
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $178 |
| GlaxoSmithKline, LLC. | 15 | $177 |
| Mallinckrodt Hospital Products Inc. | 1 | $39 |
| Actelion Pharmaceuticals US, Inc. | 2 | $37 |
| Insmed, Inc. | 1 | $25 |
| United Therapeutics Corporation | 1 | $23 |
| Amgen Inc. | 1 | $19 |
Products named: FASENRA, NUCALA, TRELEGY ELLIPTA, ACTHAR, UPTRAVI, Arikayce, Tyvaso, AIRSUPRA.
Industry payments across OH — which companies pay providers there.
